173 filings
Page 2 of 9
8-K
fooih38tps n1t1tz2
5 Jun 23
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
8:28am
8-K
wsqed281lr55
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
7jf99ps vrg7i7zo4jh
15 May 23
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
4:25pm
8-K
lgobof 61atanitj5sfh
31 Mar 23
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results
4:45pm
8-K
7jl5cbpv
3 Feb 23
Regulation FD Disclosure
6:03am
8-K
cheh51lqo7o3s p7li
14 Dec 22
Regulation FD Disclosure
8:45am
8-K
wve8pas3drl2sh670a
9 Dec 22
Other Events
4:30pm
8-K
swq6 n9r3bxy
14 Nov 22
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results
8:15am
8-K
8kmyvhglplaku85qvhm
9 Nov 22
Material Modifications to Rights of Security Holders
8:19am
8-K
z7cndcvvz64wg0lq mxr
8 Nov 22
Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split
4:37pm
8-K
lgo8lpmdb8pj mw71x3e
3 Nov 22
Timber Pharmaceuticals Announces Halt of Common Stock Trading
8:41am
8-K
y4bvtk5e
25 Oct 22
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital
8:30am
8-K
0c8svrjqq8yqpfdindv
3 Oct 22
Timber Pharmaceuticals Announces $1.3 Million Registered Direct Offering
4:15pm
8-K
lyy4vnbtoa0
12 Sep 22
Regulation FD Disclosure
4:43pm
8-K
97oy5zp5
2 Sep 22
Completion of Acquisition or Disposition of Assets
4:16pm
8-K
mzgpf70j
29 Aug 22
Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing Deficiency
4:16pm
8-K
xklj79jg
12 Aug 22
Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2022 Financial Results
2:30pm
8-K
q2q4z sxm
8 Aug 22
Securities Purchase Agreement
4:36pm
8-K
ih8shfmvn7
1 Aug 22
Entry into a Material Definitive Agreement
5:44pm
8-K
ny3nl
26 Jul 22
Entry into a Material Definitive Agreement
4:06pm